Rejuvenating, Anti-aging Benefits of Vital Cell®
Clinical Trial of Age-Related Health Problems in 150 Adults
By Jim English
Vital Cell® is an advanced herbal
formula designed to counter a host
of problems commonly associated
with human aging. By supporting healthy
microcirculation Vital Cell has been
shown to enhance energy levels, reduce
plasma viscosity, enhance microcirculation
and reverse capillary damage.
Additionally, by promoting improved
internal organ function and speeding
removal of cellular waste products such as
lipofuscin, Vital Cell can support the
immune system to increase resistance to
illness and improve overall health (see
Restoring Thymus Function for Enhanced
Immune Support, on page 3).
The following article is a shortened
summary condensed from a large clinical
trial of Vital Cell involving 150 patients,
aged 55 to 89 years old. In their paper the
study researchers documented significant
improvements in a wide range of symptoms
commonly associated with age-related
degenerative health issues.
Arterial Support
With advancing age, arteries tend to thicken
as fatty deposits accumulate on the
inner lining of arterial walls, especially in
the coronary and cerebral arteries. These
deposits reduce arterial circumference and
impair blood vessel elasticity, resulting in
reduced blood flow to heart tissues.
Common symptoms usually include chest
distress, palpitations, insomnia, and pain
due to insufficient blood supply to the
coronary arteries.
Angina: Prior to treatment, 25 of the
enrolled patients had been diagnosed with
angina pectoris (chest pain or discomfort
due to coronary heart disease and reduced
blood flow to the heart). After one month
of taking Vital Cell, 23 of the 25 patients
(92 percent) were completely free of
symptoms, and the remaining two patients
reported that their symptoms were significantly
reduced.
Chest Tightness: Before taking Vital
Cell, 106 patients reported experiencing
chest pains. After receiving Vital Cell for
one month, only two of the 106 patients
(1.3 percent) continued to feel chest pains.
Palpitations: Of 86 patients experiencing
unpleasant sensations, including irregular
and/or forceful beating of the heart, 82
reported complete relief from symptoms
one month after treatment, and only four
patients reported continued symptoms.
Coughing, Shortness of Breath
Human aging is associated with the partial
or complete wasting (atrophy) of the
adrenal cortex and sex glands, resulting
in deterioration of the mononuclear
phagocyte system (part of the immune
system) and a decline in antibody production
for protection from infection.
Other factors, such as a narrowing or
obstruction of the pulmonary arteries,
contribute to inflammation of the
bronchial walls, resulting in lung congestion,
edema, fibroplastic proliferation
and narrowing of the bronchial
tubes. Symptoms often include chronic
coughing and shortness of breath.
Coughing: Before receiving Vital Cell,
patients were questioned about their
coughing patterns. Coughing fits lasting
five minutes or longer, and occurring in
both the morning and evening, were considered
diagnostically relevant. Thirty-six
patients reported that they experienced
bouts of coughing lasting longer than five
minutes in both morning and evening.
After taking Vital Cell for one month,
34 patients reported improvement (94
percent), and only two cases reported
coughing fits still lasting for more than
five minutes.
Shortness of Breath: To determine
shortness of breath, all 150 patients were
required to climb one flight of stairs, after
which their breathing was monitored and
recorded. These records were compared
to records gathered at intake.
At the start of the study, 42 patients
experienced shortness of breath during the
stair test. At the conclusion of the study
only seven patients still experienced shortness
of breath, while 35 patients (83 percent)
were able to complete the stair test
without difficulty.
Dizziness
Dizziness is one of the most common
complaints of the elderly. Originating in
the central vestibule of the brain stem,
age-related dizziness is often related to
impaired blood flow caused by hardening
of the arteries.
Prior to the trial, 69 patients reported
experiencing bouts of dizziness. After one
month of treatment, 59 patients (85 percent)
reported that their symptoms had
abated, while only 10 patients (15 percent)
still experienced episodes of dizziness.
Edema, Puffiness of Lower Limbs
In the elderly, as plasma albumin levels
decrease, colloid osmotic pressure of the
plasma is reduced as well. Additionally,
as aging blood vessels become increasingly
permeable, plasma levels of sex
hormones decline, leading to increased
retention of water and sodium. Together
these changes contribute to increased
accumulation of fluid (edema) and
swelling in the lower limbs.
Vital Cell has previously been shown
to increase plasma albumin and sex hormone
levels, leading researchers to theorize
that the formula would aid in reducing
lower limb edema.
Prior to administration of Vital Cell,
32 subjects were diagnosed with edema of
the lower limbs, including edema resulting
from chronic heart failure and chronic
renal dysfunction. After one month of
treatment with Vital Cell, 30 patients (94
percent) were free of edema, and only two
patients still showed signs of swelling of
the lower limbs.
Loss of Appetite
The gradual decline of the hypothalamuspituitary-
adrenal cortex is a hallmark of
human aging. As the thyroid glands deteriorate,
secretion of digestive enzymes
and gastric juices are reduced, resulting in
a loss of appetite.
Before receiving Vital Cell, 56
patients suffered from diminished
appetite. At the conclusion of the study,
49 patients (87 percent) reported that their
appetite had returned, and only seven
patients continued to show signs of poor
appetite after treatment.
Blood Pressure
In the elderly, elevated systolic and diastolic
blood pressure levels result from
the loss of elasticity in the arterial walls.
Other contributing factors include narrowing
of the diameter of blood vessels,
increased resistance to peripheral blood
flow, and elevated blood serum viscosity.
Vital Cell has been shown to exert positive
anti-aging effects to aid in normalizing
blood pressure levels.
Researchers measured blood pressure
levels of patients before and after treatment
with Vital Cell. Of the 150 volunteers,
only those with a systolic pressure
greater than 160 and a diastolic pressure
greater than 90 were selected for further
evaluation, for a total of 62 subjects.
Before administration, 26 patients
had blood pressure measurements greater
than 160/90. The highest systolic pressure
was 207, and the highest diastolic pressure
was 120. The average systolic pressure
was 149, and the average diastolic
pressure was 89.
After taking Vital Cell for 30 days,
blood pressure readings greater than
160/90 were seen in only three subjects.
The highest systolic pressure of those
who were treated was 150, while the average
dropped to 127. The highest diastolic
pressure fell to 100, while the average fell
to 79.
Improved ECG
Of the 150 study patients admitted to the
study, 48 had been previously diagnosed
with coronary heart disease. Prior to
receiving Vital Cell, ECG abnormalities
were detected in 35 patients, including STT
changes, frequent premature atrial beat,
atrial fibrillation and frequent premature
ventricular beat. Following treatment 30
patients (85 percent) were shown to be free
of the previously detected ECG abnormalities,
while five patients (15 percent) were
found to still have abnormal ECGs.
Blood Flow
Researchers randomly gathered blood
samples from 41 patients (20 males and 21
females) prior to treatment and at the end
of the study. The examiners conducted the
following tests on blood samples:
- Whole-blood specific viscosity
- Erythrocyte sedimentation rate
- Hematocrit (red blood cell count)
- Plasma specific viscosity
- Erythrocyte electrophoresis
While there were no detectible changes in
erythrocyte sedimentation rate or hematocrit
after treatment, test results revealed
significant improvements in whole-blood
specific viscosity, plasma specific viscosity
and erythrocyte electrophoresis.
Microcirculation
Researchers randomly selected 51 patients
to measure circulation in nail-fold microcapillaries
prior to receiving Vital Cell, and
again at the end of the study. Microscopic
observations revealed significant improvements
in the speed of blood flowing
through the microcapillaries of the nail
folds after treatment.
Immune Function
To evaluate Vital Cell's impact on immune
function, the researchers selected 44
patients for blood tests. Efficiency of cellular
immunity was determined by measuring
lymphocyte transformation rate, and
the immune function of red blood cells
was determined by erythrocyte rosette (Erosette)
formation.
Lymphocyte Transformation Rate:The average value before administration
of Vital Cell was 53.944. This value rose to
59.444 after one month of treatment. This
was a considerable increase showing statistical
significance (P<0.05).
Test of Rosette Formation: Average
value prior to administration of Vital Cell
was 52.176. This value increased greatly
to 54.647 after treatment. The difference
was statistically significant. (P<0.05).
Metabolism of Plasma Proteins
Albumin is an abundant blood plasma protein
produced by the liver and secreted into
the blood. In addition to preventing the
leakage of fluids from the capillaries into
surrounding tissues, albumin aids in transporting
small molecules, such as calcium,
unconjugated bilirubin, free fatty acids, cortisol and thyroxine. Serum albumin levels
can serve as a useful marker of
chronic liver disease and nutritional status.
Researchers measured albumin levels
in 44 patients prior to administration
with Vital Cell and again at the end of
treatment.
Plasma Albumin: The average
value of plasma albumin was 4.573
before Vital Cell, and rose to 4.768 by
the end of the study. These numbers
were statistically significant (P<0.01).
Plasma Globulin: Prior to administration,
average plasma globulin was
2.734. This number decreased to 2.564,
indicating a statistically significant
improvement.
Plasma Albumin/Globulin Ratio:
The ratio before treatment was 1.702,
and increased to 1.897 following the
treatment period. The difference indicated
a great statistical significance
(P<0.01).
Summary
Vital Cell has been shown to have
excellent therapeutic actions on such
elderly disorders as chest tightness,
insomnia, chest pains, coughing,
shortness of breath, heart palpitations,
dizziness and lack of appetite.
Vital Cell has been shown to promote
healthy blood circulation while
supporting expansion of coronary
arteries and arterioles of the brain and
lungs, increasing blood flow in coronary
vessels, improving vessel elasticity,
enhancing T-cell immunity and
promoting the synthesis and metabolism
of proteins.
These findings indicate that Vital
Cell can serve as a valuable antiaging
formula to aid in reversing various disorders
affecting the elderly, such as
insufficient blood supply to the brain,
coronary heart disease, chronic bronchitis,
and hypoproteinemia, without
the risk of adverse or toxic side
effects.